Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients
Heise, T., Graefe-Mody, E. U., Hüttner, S., Ring, A., Trommeshauser, D., Dugi, K. A.
Published in Diabetes, obesity & metabolism (01.08.2009)
Published in Diabetes, obesity & metabolism (01.08.2009)
Get full text
Journal Article
Phase i study of the Plk1 inhibitor BI 2536 administered intravenously on three consecutive days in advanced solid tumours
Frost, A, Mross, K, Steinbild, S, Hedbom, S, Unger, C, Kaiser, R, Trommeshauser, D, Munzert, G
Published in Current oncology (Toronto) (01.02.2012)
Published in Current oncology (Toronto) (01.02.2012)
Get full text
Journal Article
Contribution of the active metabolite M1 to the pharmacological activity of tesofensine in vivo: a pharmacokinetic‐pharmacodynamic modelling approach
Lehr, T, Staab, A, Tillmann, C, Nielsen, E Ø, Trommeshauser, D, Schaefer, H G, Kloft, C
Published in British journal of pharmacology (01.01.2008)
Published in British journal of pharmacology (01.01.2008)
Get full text
Journal Article
Ibuprofen extrudate, a novel, rapidly dissolving ibuprofen formulation: relative bioavailability compared to ibuprofen lysinate and regular ibuprofen, and food effect on all formulations
Klueglich, Matthias, Ring, Arne, Scheuerer, Stefan, Trommeshauser, Dirk, Schuijt, Chris, Liepold, Bernd, Berndl, Gunther
Published in Journal of clinical pharmacology (01.09.2005)
Published in Journal of clinical pharmacology (01.09.2005)
Get more information
Journal Article
Contribution of the active metabolite Ml to the pharmacological activity of tesofensine in vivo : a pharmacokinetic-pharmacodynamic modelling approach
LEHR, T, STAAB, A, TILLMANN, C, NIELSEN, E. Ø, TROMMESHAUSER, D, SCHAEFER, H. G, KLOFT, C
Published in British journal of pharmacology (2008)
Get full text
Published in British journal of pharmacology (2008)
Journal Article
A phase I dose escalation trial of BI 2536, a novel Plk1 inhibitor, with standard dose pemetrexed in previously treated advanced or metastatic non-small cell lung cancer (NSCLC)
Ellis, P. M., Chu, Q. S., Leighl, N. B., Laurie, S. A., Trommeshauser, D., Hanft, G., Munzert, G., Gyorffy, S.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
A phase I study of two administration schedules of the Polo-like kinase 1 inhibitor BI 2536 in patients with advanced solid tumors
Munzert, G., Steinbild, S., Frost, A., Hedborn, S., Rentschler, J., Kaiser, R., Trommeshauser, D., Hoffmann, M., Steegmaier, M., Mross, K.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
A phase I repeated dose escalation study of the Polo-like kinase 1 inhibitor BI 2536 in patients with advanced solid tumours
Hofheinz, R., Hochhaus, A., Al-Batran, S., Nanci, A., Reichardt, V., Trommeshauser, D., Hoffmann, M., Steegmaier, M., Munzert, G., Jäger, E.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
The effect of lipid composition and physical state of phospholipid monolayer on the binding and incorporation of a basic amphipathic peptide from the C-terminal region of the HIV envelope protein gp41
Trommeshauser, Dirk, Krol, Silke, Bergelson, Lev D, Galla, Hans-Joachim
Published in Chemistry and physics of lipids (01.09.2000)
Published in Chemistry and physics of lipids (01.09.2000)
Get full text
Journal Article